Moelis & Company
NYSE:MCFinancial - Capital Markets
-$1.14 today
- Market cap
- $4.03B
- Beta
- 1.85
- P/E (TTM)
- 22.2
- EPS (TTM)
- $2.93
- Dividend yield
- 3.99%
Volume 0.66M
Average 1.10M
MC Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Moelis & CompanyNYSE: MC
Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026
Capital expenditures grows, but more slowly than its trailing trend
Q2 FY2026 capital expenditures of $13.67M (cash outflow) rose 187.6% year over year, behind the +348.6% change in trailing-twelve-month capital expenditures. Sequentially, it rose 6.9% from the prior quarter. Over 3 fiscal years it compounded at +82.7% a year.
Context
- Capital expenditures amounted to 2.4% of revenue in FY2025, up 1.4 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +187.6% toward the trailing-twelve-month pace of +348.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (36.33M) USD
- Year-over-year change
- -200.4%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (36.33M) | -200.4% |
| FY2024 | 2024-12-31 | (12.09M) | +27.6% |
| FY2023 | 2023-12-31 | (16.7M) | -180.3% |
| FY2022 | 2022-12-31 | (5.96M) | +63.7% |
| FY2021 | 2021-12-31 | (16.43M) | — |
Capital Expenditures vs competitors
How MC compares with its peers on the latest reported figures
- MC's LTM Jun 2026 capital expenditures of $54.93M is the 6th largest of the 11 companies compared; the peer median is $55.62M.
- Its year-over-year change of +348.6% is the highest of 10, against a peer median of +0.7%.
- Capital expenditures amounts to 3.5% of revenue for MC, versus a peer median of 1.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.28B | +97.3% | — | 558.5% | |
| LTM Jun 2026 | $197M | +1.5% | +27.4% | 1.2% | |
| LTM Jun 2026 | $73.2M | +18.8% | +9.7% | 0.0% | |
| LTM Jun 2026 | $63.91M | -5.7% | +4.0% | 1.9% | |
| LTM Jun 2026 | $60.04M | +0.7% | +32.7% | 1.5% | |
| LTM Jun 2026 | $54.93M | +348.6% | +82.7% | 3.5% | |
| LTM Jun 2026 | $51.19M | +223.1% | +137.3% | 2.7% | |
| LTM Jun 2026 | $40.34M | -23.7% | -45.9% | 4.6% | |
| LTM Jun 2026 | $19.24M | -46.9% | +4.2% | 0.9% | |
| LTM Sep 2026 | $9.21M | -38.1% | -13.6% | 0.3% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MC) | $55.62M | +0.7% | +7.0% | 1.3% | |
Competitors are the stored peer set for MC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 422.98M | 168.68M | (24.7M) | 151.49M | 233.04M |
| Depreciation & Amortization | 7.24M | 7.98M | 8.32M | 10.44M | 11.88M |
| Deferred Income Tax | 22.86M | 26.79M | 0 | 35.07M | 0 |
| Stock-Based Compensation | 167.94M | 128.94M | 158.19M | 161.45M | 0 |
| Change in Working Capital | 346.92M | (314.15M) | 34.05M | 77.73M | 53.77M |
| Accounts Receivables | 26.94M | (20.32M) | 0 | (1.84M) | (36.75M) |
| Inventory | 264.76M | 0 | 0 | 0 | 0 |
| Accounts Payables | 52.87M | (45.04M) | 23.74M | 21K | 18.23M |
| Other Working Capital | 2.35M | (248.79M) | 10.3M | 79.55M | 72.29M |
| Other Non-Cash Items | (30.96M) | 14.76M | (17.38M) | (8.69M) | 277.61M |
| Operating Cash Flow | 936.98M | 32.99M | 158.47M | 427.49M | 576.3M |
| Capital Expenditures | (16.43M) | (5.96M) | (16.7M) | (12.09M) | (36.33M) |
| Acquisitions (Net) | 29.16M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (486.12M) | (334.74M) | (210.58M) | (169.46M) | (524.75M) |
| Sales of Investments | 456.3M | 332.52M | 275.85M | 205.24M | 346.62M |
| Other Investing Activities | 70K | (3M) | 0 | (6.58M) | 18.5M |
| Investing Cash Flow | (17.01M) | (11.18M) | 48.57M | 17.11M | (195.97M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (104.15M) | (147.54M) | (47M) | (10.84M) | (74.59M) |
| Dividends Paid | (479.96M) | (174.65M) | (182.16M) | (184.16M) | (208.7M) |
| Other Financing Activities | (18.43M) | (4.71M) | (15K) | (20.1M) | (602K) |
| Financing Cash Flow | (602.54M) | (326.9M) | (229.17M) | (215.11M) | (283.9M) |
| Effect of Forex Changes | 305K | (8.39M) | 1.8M | (3.53M) | (243K) |
| Net Change in Cash | 317.73M | (313.48M) | (20.32M) | 225.96M | 96.19M |
| Free Cash Flow | 920.55M | 27.04M | 141.78M | 415.39M | 539.97M |
Moelis & Company
NYSE:MC
Intrinsic Alpha fair value
Locked
Current Price
$54.56
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.